Avalyn Pharma Inc. (AVLN) Form 10-Q Quarterly Reports
Avalyn Pharma Inc. (AVLN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVLN
CIK: 1540171
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBrian Emrick
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394342 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-09-15 | 3 | 0001193125-26-394320 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | 8-K | 0001193125-26-393081 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001388325-26-000044 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345820 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345807 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0002149521-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002206 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-29 | 8-K | 0001193125-26-292834 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001193125-26-273405 | View SEC Doc Filr Page |
| 10-Q | 2026-06-03 | 2026-03-31 | 10-Q | 0001193125-26-254623 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001193125-26-254581 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-08 | — | SCHEDULE 13D Filing | 0000899140-26-000428 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-08 | — | SCHEDULE 13D Filing | 0001072613-26-000386 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-07 | — | SCHEDULE 13G Filing | 0001193125-26-212017 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | 4 Filing | 0001388325-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-05 | — | SCHEDULE 13G Filing | 0000315066-26-000743 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | 4 | 0001193125-26-205201 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-29 | 4 | 0001193125-26-202381 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 | 0001193125-26-201894 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 | 0001193125-26-201887 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-29 | 4 | 0001193125-26-201875 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-29 | 4 | 0001193125-26-201870 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-29 | 4 | 0001193125-26-201868 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-29 | 4 | 0001193125-26-201867 | View SEC Doc Filr Page |